Relating to the regulation of medical cannabidiol, by altering the list of debilitating medical conditions and changing the definition of medical cannabidiol under the medical cannabidiol Act, and exempting sales of medical cannabidiol products from Iowa sales tax

The bill requires that any certification made by a health care practitioner for a patient for a debilitating medical condition not explicitly included on the list of debilitating medical conditions shall be made by a health care practitioner pursuant to reasonable medical evidence, in good faith, in the best interest of the patient, without fraudulent intent, and with the same reasonable medical judgment and prudence exercised according to generally accepted medical practice. Under current law, a health care practitioner may only issue a written certification for a debilitating medical condition explicitly included on the list of debilitating medical conditions. A written certification may be renewed on an annual basis if the health care practitioner determines that the patient continues to suffer from the debilitating medical condition. The bill alters the definition of medical cannabidiol by removing the requirements that medical cannabidiol be any pharmaceutical grade cannabinoid and that the cannabinoid has a tetrahydrocannabinol (THC) level of 3 percent or less. The bill removes the authority of the medical cannabidiol board to recommend increasing the THC level in medical cannabidiol to more than 3 percent. The bill exempts sales of medical cannabidiol products by a medical cannabidiol manufacturer or a medical cannabidiol dispensary pursuant to Code chapter 124E from sales tax.